GLP-1 reduces risk of 10 types of cancer compared with insulin in type 2 diabetes patients
Add a topic to an email alert Get emails when new articles are published Enter your email address to receive emails when new articles are published.…
Add a topic to an email alert Get emails when new articles are published Enter your email address to receive emails when new articles are published.…
In a recently published study, BMC Public HealthResearchers investigated the impact of lifestyle and dietary habits on depression in diabetic patients. Findings indicate that lifestyle patterns significantly influence depression and…
Getting people with type 2 diabetes to take that final step in behavior change could significantly improve their blood sugar levels over time. The question is how to do it…
This transcript has been edited for clarity. The U.S. Food and Drug Administration's Endocrine Advisory Committee voted against recommending approval of once-weekly insulin Icodec to treat people with diabetes. Type…
For the second year in a row, Walgreens has participated as a sponsor of “Children with Diabetes,” an initiative to support children with diabetes. Walgreens, a nonprofit organization dedicated to…
Navigating the Healthcare Industry Healthcare Brew informs administrators and healthcare providers by covering drug developments, healthcare startups, emerging technologies and their impact on hospitals and healthcare providers. Diabetic patients with…
Diabetes is currently the eighth leading cause of death and disability worldwide, with approximately 500 million people suffering from the disease. The prevalence of diabetes is also expected to increase,…
Hospitalized patients with complex dietary restrictions often suffer from hyperglycemia, a condition in which blood glucose levels are high. This occurs in approximately one-quarter to one-half of these patients and…
Study setting and patients In this double-blind, randomized trial, adult patients with type 2 diabetes received placebo or dapagliflozin 10 mg once daily for 12 months. The study began on…
Study design and participants A prospective, open-label, randomized study was conducted at the Obesity Clinic of the University Hospitals of Leuven, Belgium. Patients were screened and considered eligible if they…